NASDAQ: ANABAnaptysbio Inc Stock Ownership - Who owns Anaptysbio?
Insider buying vs selling
Have Anaptysbio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Hollings Renton | Director | 2026-10-01 | 5,000 | $18.03 | $90.15kBuy |
| Hollings Renton | Director | 2026-10-01 | 5,000 | $49.87 | $249.37kSell |
| John P. Schmid | Director | 2026-03-30 | 7,527 | $56.70 | $426.78kSell |
| John P. Schmid | Director | 2026-03-30 | 522 | $57.40 | $29.96kSell |
| John P. Schmid | Director | 2026-03-30 | 12,596 | $55.71 | $701.71kSell |
| Daniel Faga | President CEO | 2026-03-27 | 2,570 | $57.91 | $148.82kSell |
| Daniel Faga | President CEO | 2026-03-27 | 490 | $59.62 | $29.22kSell |
| Daniel Faga | President CEO | 2026-03-27 | 550 | $60.63 | $33.34kSell |
| Daniel Faga | President CEO | 2026-03-27 | 1,012 | $62.15 | $62.90kSell |
| Daniel Faga | President CEO | 2026-03-27 | 2,592 | $63.35 | $164.20kSell |
ANAB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ANAB insiders and whales buy or sell their stock.
ANAB Shareholders
What type of owners hold Anaptysbio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ecor1 Capital LLC | 90.34% | 27,008,838 | $1.27B | Insider |
| Oleg Nodelman | 23.92% | 7,151,624 | $335.48M | Insider |
| Avalon Ventures VII L P | 6.81% | 2,036,932 | $95.55M | Insider |
| Holdings A. Novo | 6.48% | 1,936,604 | $90.85M | Insider |
| Frazier Healthcare VII LP | 4.30% | 1,284,903 | $60.27M | Insider |
| Frazier Healthcare V LP | 3.55% | 1,062,321 | $49.83M | Insider |
| James N. Topper | 3.28% | 980,512 | $46.00M | Insider |
| Daniel Faga | 1.66% | 495,965 | $23.27M | Insider |
| Nicholas Lydon | 0.91% | 271,106 | $12.72M | Insider |
| Hamza Suria | 0.23% | 68,600 | $3.22M | Insider |
ANAB vs Biotech Stocks
Anaptysbio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.